The forecast for antibacterial medicine sales in Norway from 2024 to 2028 shows a consistent decline in US Dollars PPP per capita. In 2023, the value stood at 8.3. The year-on-year variation highlights a gradual decrease: -1.22% from 2024 to 2025, -1.23% from 2025 to 2026, and -2.50% from 2026 to 2027, followed by a -1.28% decline from 2027 to 2028. Over the last two years leading up to 2023, sales were stable with negligible variation, but a noticeable negative CAGR of -1.47% is observed over the past five years.
Future trends to watch for include the impact of increased antibiotic resistance affecting the demand for traditional antibacterials, advancements in alternative treatments, governmental regulations promoting antibiotic stewardship, and potential public health campaigns aimed at reducing the overuse of antibacterial medicines.
